Blue Trust Inc’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$266 Buy
+6
New +$308 ﹤0.01% 2347

Other funds holding BBC

Blue Trust Inc's BBC Position: Q3 2026 in Review

Blue Trust Inc opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q3 2026: 6 shares worth $266. The stake represents ﹤0.01% of the portfolio and ranks #2347 among its holdings.

3 funds tracked by Wall St. Rank hold BBC as of Q3 2026.

  • Blue Trust Inc held 6 shares of Virtus Biotech Clinical Trials ETF worth $266 as of Q3 2026.
  • Virtus Biotech Clinical Trials ETF was a new Blue Trust Inc position in Q3 2026.
  • Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2347 holding.
  • 3 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.